Advancing Infection Prevention Through Scientific Innovation
Patented Infection Control
JSQ Lifesciences develops and commercialises advanced antiseptic and disinfection solutions designed to address the growing challenge of healthcare-associated infections and antimicrobial resistance.
By combining proven science with clinical evidence, we deliver innovative products that support safer patient care, improved health services outcomes, and enhanced environmental hygiene across healthcare settings.
About JSQ Lifesciences
Global Innovation. Trusted Protection.
JSQ Lifesciences is focused on introducing novel infection prevention solutions to the Indian healthcare market. Our products are developed to meet the evolving needs of hospitals, medical professionals, and patients in an era of increasing antimicrobial resistance.
Our portfolio includes:
- Antiseptic Solutions
- Surface Disinfectants
- Antiseptic Wipes
- Disinfectant Wipes
- Gel (coming soon)
“The most effective antiseptic agent available today for high-risk clinical environments.”
Dr. Anil Vaidya – Transplant Surgeon who performed Asia’s first En-bloc liver heart transplant
The most effective antiseptic agent available today for high-risk clinical environments
Prof Dr.Anil Vaidya, Chair of Abdominal Organ Transplantation, MGM Healthcare, Chennai.
Patented Products
- Liquid antiseptic
- Liquid disinfectant
- Antiseptic wipe
- Disinfectant wipe
Merge this section with the one below.
Highlights of SQ53
Broad-Spectrum Performance
Extensively evaluated by independent international laboratories, our patented formulations such as SQ53 have passed tests which demonstrate activity against a wide range of clinically significant microorganisms, including bacteria, viruses, fungi, and multidrug-resistant organisms.
For example:
- ESKAPE pathogens
- NDM-1 producing organisms
- ESBL and colistin-resistant E. coli
- Coronaviruses
- H1N1 Influenza
- Ebola virus
- Candida auris
- Extended residual antimicrobial activity exceeding 24 hours
- Water-based, skin-safe, and non-irritating.
- Non-staining, non-corroding multi surface use
- Supports biofilm management through the inclusion of PHMB
- No evidence of antimicrobial resistance development
- Clinical studies have demonstrated reductions in healthcare-associated infections, including catheter-related bloodstream infections (CRBSIs)